H7N7 low-pathogenicity avian influenza virus (H7N7-LPAIV) incursions have preceded emergence of H7N7 high-pathogenicity (HP)AIV at several European layer hen outbreaks. Evidence from a UK layer H7N7-HPAIV (2008) outbreak informed in vivo modelling of sequential events, beginning with H7N7-LPAIV precursor incursion. Three groups of 17-week-old (point-of-lay) hens were inoculated with three precursor H7N7-LPAIV candidates which possessed: Group 1 – the classic LPAIV single-basic cleavage site (CS) (H7N7-SBCS); Group 2 - the dibasic CS (H7N7-DBCS) discovered at the outbreak (both represented direct H7N7-HPAIV (2008) precursors); Group 3 - a related European H7N7-LPAIV (2008) which possessed a DBCS within its haemagglutinin (HA) gene which was highly-conserved with the HA of the UK (2008) outbreak H7N7-HPAIV, but its other genetic segments differed. In Groups 1-3, initial H7N7-LPAIV exposure caused limited viral shedding, restricted H7-antibody responses and no deaths, by 14-days post-inoculation (dpi). H7N7-HPAIV challenge of all groups (n=8 per challenge group, including AIV-na?ve hens in Group 4) followed at 14 dpi. Prior H7N7-LPAIV inoculation protected against mortality due to H7N7-HPAIV challenge to varying degrees, with eight (100%), seven (87.5%), six (75%) and three (37.5%) survivors in Groups 1-4, respectively, by study-end (14-days post-challenge), when all 24 survivors had strongly seroconverted. Among challenge survivors belonging to Groups 1-3, 20/21 (95%) shed H7N7-HP, indicating that immunity acquired during initial H7N7-LPAIV exposure did not arrest H7N7-HPAIV replication. Despite prior H7N7-LPAIV incursion which elicited additional clinical protection against H7N7-HPAIV challenge, we showed how an emergent H7N7-HPAIV may represent a source for onward spread and further HPAIV outbreaks.